Search results
FDA OKs Iqirvo, First-in-Class PPAR Treatment for PBC
Medscape· 6 days agoIqirvo (elafibranor) is indicated for adults with primary biliary cholangitis who do not respond to or cannot tolerate ursodeoxycholic acid.
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster | The Motley Fool
The Motley Fool· 2 days agoEli Lilly's (LLY -0.55%) name has become somewhat synonymous with its work in diabetes and obesity...
Move over, GLP-1s. Syntis launches with clinical-stage obesity pill to mimic gastric bypass surgery
FierceBiotech· 6 days agoGLP-1 agonists and their next-gen successors may still be center stage in the red-hot obesity space,...
Eli Lilly stock hits all-time high: What’s been driving the pharma giant’s share price higher?
Bankrate via Yahoo Finance· 4 days agoThe company is showing signs of disruptive growth. ...and Mounjaro. These injectable medications...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 4 days agoBlue Cross Blue Shield of Michigan is dropping coverage of popular weight loss drugs, citing...
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive via Yahoo Finance· 6 days agoOn Wall Street, analysts expect an approval would add another blockbuster product to Lilly’s...
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
The Motley Fool via AOL· 8 hours agoThis blockbuster drug could have an edge For those unaware, the United States Food and Drug Administration (FDA) has already approved tirzepatide for treating type-2 diabetes ...
Small Biotech Crushed On Obesity Switch After Glaucoma Flop
Investor's Business Daily· 6 days agoSkye Bioscience (SKYE) had been testing a treatment for a form of glaucoma. Now, Skye says it's...
Novo’s blockbuster obesity drug Wegovy under fire in Denmark
Detroit News· 3 days agoA Danish drug oversight panel advised doctors to restrict prescriptions of Novo Nordisk A/S’s...
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA...
Benzinga via Yahoo Finance· 3 days agoVivani Medical, Inc. (NASDAQ:VANI) announced that the U.S. FDA has cleared its Investigational New...